Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review.

The damaging effects of Sars-CoV-2 on cardiac tissue may be intensified with the presence cardiocirculatory pathologies. use clinical biomarkers has grown, in order to monitor this cardiotoxicity early. In sense, study aimed investigate, through an integrative review, main injury associated comorbidities patients COVID-19. A systematic bibliographic search was conducted July 26, 2020, Scopus database. Of total 669 publications purchased, only 40 articles were eligible for review. From content these publications, 16 systemic and inflammatory that are part findings critically ill COVID-19 identified. Most male, had a mean age 63 years, pre-existing comorbidities, such as hypertension, diabetes mellitus, coronary artery disease, cerebrovascular chronic obstructive pulmonary disease. Cardiac injuries infected related increase observed most individuals. Finally, it is expected physicians' awareness biochemical markers non-invasive injury, diagnosis prognosis, unusual extrapulmonary pathophysiological presentations during infection by